Security key
00688A106
ADIAL PHARMACEUTICALS INC COM NEW - COM (ADIL)
CUSIP: 00688A106
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / COM
- Total 13F shares
- 3,600
- Total 13F value
- $3,636
- Share change
- +3,600
- SEC-reported price per share
- $1.01
- Number of holders
- 1
- Value change
- +$3,636
- Number of buys
- 1
Report period
Q4 2024
Institutions
1
Top holders
1
ADIL full security history
Ownership snapshot
Full 13F holder table
ADIAL PHARMACEUTICALS, INC. SEC filings
ADIAL PHARMACEUTICALS, INC. company facts
Broader feeds
Ownership snapshot
Top reported holders of ADIL - ADIAL PHARMACEUTICALS INC COM NEW - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
William B. Stilley III
Disclosed value leader
William B. Stilley III
Comparable rows
0/15
Latest evidence
30 Sep 2024
3/4/5
13F
Highest disclosed value: $530,200
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
William B. Stilley III has the largest disclosed position value at $530.2K.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens William B. Stilley III's linked filing trail.
Disclosed position value
Top 5
William B. Stilley III
$530.2K
Joseph Truluck
$111.4K
Manchester Capital Management LLC
$48K
GEODE CAPITAL MANAGEMENT, LLC
$45.4K
CITADEL ADVISORS LLC
$33.2K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| William B. Stilley III |
3/4/5
Director
|
—
mixed-class rows
|
$530,200
1,311,779 shares
mixed-class rows
|
— | 23 May 2023 |
| Joseph Truluck |
3/4/5
Chief Financial Officer
|
—
mixed-class rows
|
$111,411
290,139 shares
mixed-class rows
|
— | 25 Mar 2024 |
| Manchester Capital Management LLC |
13F
Company
|
—
denominator unverified
|
$48,049
48,097 shares
|
— | 30 Sep 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$45,420
45,466 shares
|
— | 30 Sep 2024 |
| CITADEL ADVISORS LLC |
13F
Company
|
—
denominator unverified
|
$33,237
33,270 shares
|
— | 30 Sep 2024 |
| BlackRock, Inc. |
13F
Company
|
—
denominator unverified
|
$27,742
27,770 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
3,600
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
0
Q4 2024 holders
1
Holder diff
1
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|